Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Mercado Libre
MELI
$92.3B
| $67.4M | 0.04% |
198,011
-43,511
| -18% | -$14.7M |
|
502
Entegris
ENTG
$19.2B
| $67.4M | 0.04% |
2,327,942
+701,141
| +43% | +$23.6M |
|
503
Bruker
BRKR
$9.14B
| $67.4M | 0.04% |
2,014,706
+1,966,906
| +4,115% | +$64.8M |
|
504
Annaly Capital Management
NLY
$16.9B
| $67.1M | 0.04% |
1,640,604
-61,825
| -4% | -$2.59M |
|
505
ACI Worldwide
ACIW
$5.88B
| $67M | 0.04% |
2,382,590
+430,312
| +22% | +$11.7M |
|
|
MYOV
506
DELISTED
Myovant Sciences Ltd.
MYOV
| $67M | 0.04% |
2,525,193
+1,401,796
| +125% | +$31.7M |
|
507
Maximus
MMS
$3.2B
| $66.7M | 0.04% |
1,025,500
-2,695
| -0.3% | -$175K |
|
508
AXIS Capital
AXS
$8.63B
| $66.7M | 0.04% |
1,155,245
+3,541
| +0.3% | +$201K |
|
509
Target
TGT
$63.7B
| $66.5M | 0.04% |
754,113
+188,206
| +33% | +$15.7M |
|
510
Fluor
FLR
$7.22B
| $66.5M | 0.04% |
1,144,660
+567,992
| +98% | +$30.9M |
|
511
HCA Healthcare
HCA
$86.4B
| $66.4M | 0.04% |
477,594
+287,802
| +152% | +$35.8M |
|
512
Black Hills Corp
BKH
$5.68B
| $66.4M | 0.04% |
1,142,903
| – | – |
|
513
Sarepta Therapeutics
SRPT
$1.68B
| $66M | 0.04% |
408,422
+406,022
| +16,918% | +$55.5M |
|
514
Acadia Pharmaceuticals
ACAD
$4.35B
| $65.2M | 0.03% |
3,142,784
-305,826
| -9% | -$4.81M |
|
515
Fair Isaac
FICO
$29.7B
| $65M | 0.03% |
284,472
+35,189
| +14% | +$7.63M |
|
516
Kimberly-Clark
KMB
$37B
| $64.3M | 0.03% |
565,480
-30,350
| -5% | -$3.4M |
|
517
Landstar System
LSTR
$6.5B
| $63.9M | 0.03% |
524,049
-4,705
| -0.9% | -$544K |
|
518
Expeditors International
EXPD
$22.4B
| $63.8M | 0.03% |
867,647
-109,918
| -11% | -$8.12M |
|
519
Eastman Chemical
EMN
$7.74B
| $63.1M | 0.03% |
659,273
+228,623
| +53% | +$22.7M |
|
|
FLIR
520
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $62.9M | 0.03% |
1,023,772
+390,135
| +62% | +$23M |
|
521
Fox Factory Holding Corp
FOXF
$779M
| $62.9M | 0.03% |
897,534
-5,724
| -0.6% | -$351K |
|
|
EPAY
522
DELISTED
Bottomline Technologies Inc
EPAY
| $62.3M | 0.03% |
857,483
-7,730
| -0.9% | -$472K |
|
|
TWTR
523
DELISTED
Twitter, Inc.
TWTR
| $62.3M | 0.03% |
2,188,145
+1,236,496
| +130% | +$43.8M |
|
|
ARGO
524
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $62.3M | 0.03% |
987,305
| – | – |
|
|
DNB
525
DELISTED
Dun & Bradstreet
DNB
| $62.2M | 0.03% |
436,633
-246
| -0.1% | -$33.4K |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.